Coherus BioSciences Inc.

04/23/2021 | Press release | Distributed by Public on 04/23/2021 06:08

Coherus Announces Toripalimab Achieved Primary Endpoints of Progression Free Survival and Overall Survival in Interim Analysis of Phase 3 Clinical Trial in First-Line[...]